Bahram Niknafs

Bahram Niknafs

Auto-generated profile, based on publicly available information

Bahram Niknafs

Kidney Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2016 in Journal of Renal Injury Prevention
Verified
Journal Article
Open access
PDF file
HTHamid Tayebi-Khosroshahi
Hamid Tayebi-Khosroshahi
AHAfshin Habibzadeh
Afshin Habibzadeh
BNBahram Niknafs
Bahram Niknafs
RGReza Ghotaslou
Reza Ghotaslou
FSFatemeh Yeganeh Sefidan
Fatemeh Yeganeh Sefidan
SPSahar Parkhide
Sahar Parkhide
Introduction: Lactulose is a prebiotic with bifidogenic and urea reduction effects. It can improve Bifidobacteria and Lactobacilli counts in healthy humans and it may possibly have similar effects in chronic kidney disease (CKD) patients. Objectives: To investigate the effect of lactulose on fecal microflora of patients with CKD. Patients and Methods: Thirty-two patients with stages 3 and 4 of CKD (43.8% male with mean age of 58.09±12.75 years) were randomly assigned to intervention (n=16) and control (n=16) groups. Patients in intervention group received 30 mm lactulose syrup three times a day for an 8-week period. Control group received placebo 30 mm three times a day. A fecal sample was obtained from all patients at the beginning and at the end of the study and Bifidobacteria and Lactobacilli was counted. Results: Creatinine (Cr) significantly decreased in intervention group (3.90±1.43 to 3.60±1.44, P=0.003) and increased in control group (3.87±2.08 to 4.11±1.99, P=0.03). Although Bifidobacterial and Lactobacilli counts were similar before intervention, they were significantly higher at the end of the study in lactulose group (P=0.01 and P=0.04, respectively). Lactulose led to significant increase in fecal Bifidobacterial counts (3.61±0.54 to 4.90±0.96, P<0.001) and Lactobacilli counts (2.79±1.00 to 3.87±1.13, P<0.001), while the change in placebo group was not significant. Conclusion: Lactulose administration will increase Bifidobacteria and Lactobacillus counts in patients with CKD.

15 April 2022 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
ARAlireza Rahmani
Alireza Rahmani
BNBahram Niknafs
Bahram Niknafs
MNMohsen Naseri
Mohsen Naseri
MNMaryam Nouri
Maryam Nouri
ATAli Tarighat-Esfanjani
Ali Tarighat-Esfanjani
Background and Aims. Diabetes is a leading cause of renal failure. High levels of oxidative stress and inflammation in patients with renal diabetes lead to various disorders and mortality. This study was performed to determine the effect of Nigella sativa (NS) supplementation on superoxide dismutase (SOD), malondialdehyde (MDA), total antioxidant capacity (TAC), high-sensitivity C-reactive protein (hs-CRP), glycosylated hemoglobin (HbA1c), fasting blood sugar (FBS), and insulin (INS) in patients with diabetes mellitus undergoing hemodialysis (HD). Methods. In this randomized, double-blind, placebo-controlled clinical trial, a total of 46 diabetic HD patients were randomly divided into NS (n=23) and placebo (n=23) groups. NS group received 2g/day of NS oil, and the placebo group received paraffin oil for 12weeks. Serum levels of SOD, MDA, TAC, hs-CRP, HbA1C, FBS, and INS were measured before and after the study. Results. Compared to baseline values, SOD, TAC, and INS levels increased, whereas MDA, hs-CRP, HbA1c, and FBS significantly decreased. After adjusting for covariates using the ANCOVA test, changes in the concentrations of SOD (p=.040), MDA (p=.025), TAC (p=<.001), hs-CRP (p=.017), HbA1c (p=.014), and FBS (p=.027) were statistically significant compared to the placebo group. Intergroup changes in INS were not significant. Additionally, there were no notable side effects during the research. Conclusions. This study found that NS supplementation significantly enhanced the levels of SOD, MDA, TAC, hs-CRP, HbA1c, and FBS in diabetic HD patients.

28 June 2022 in Canadian Journal of Infectious Diseases and Medical Microbiology
Verified
Journal Article
Open access
PDF file
NENarges Eslami
Narges Eslami
VPVahdat Poortahmasebi
Vahdat Poortahmasebi
JSJavid Sadeghi
Javid Sadeghi
RGReza Ghotaslou
Reza Ghotaslou
BNBahram Niknafs
Bahram Niknafs
MOMahin Ahangar Oskouee
Mahin Ahangar Oskouee
Regardless of the extensive screening for the detection of hepatitis B surface antigen (HBsAg), hemodialysis (HD) patients are still severely at the risk of occult hepatitis B virus infection (OBI), especially in developing countries. OBI is defined as the presence of HBV DNA with undetectable HBsAg in the liver and/or Serum. This study aims to determine the prevalence of OBI in HD patients in East Azerbaijan Province, northwest of Iran, and inquire about the mutations in the detected HBsAg. In this cross-sectional descriptive study, ELISA method assessed serum and plasma samples of 118 HBsAg-negative patients undergoing HD treatment for HBV serological markers (HBsAg and Anti-HBc). Specific primers by nested polymerase chain reaction have been utilized to examine HBV DNA; also, direct sequencing of surface genes was carried out to characterize the viral genotypes and S gene mutations. Finally, followed by real-time PCR, the quantity of viral load in OBI-positive patients was determined. A total of 118 HD patients were included (63.6% were male and 36.4% female), with an overall mean age of 60.8 ± 12.8 years old. The prevalence of antihepatitis B core antibody (Anti-HBc) in the study population was 26.3% (31/118). Five patients (4.2%) were positive for HBV DNA and labeled OBI-positive; their plasma HBV-DNA load was less than 100 IU/ml. Following the phylogenetic analysis, the samples with OBI roughly belonged to genotype D, subtype ayw2 and only two had mutations within the S ’gene’s major hydrophilic region (MHR), including T123I, C124F, and P127T. This study reports the prevalence of OBI in the HBsAg-negative HD patients being at a rate of 4.2%, which can be a clinically vital consideration in this region. HBV serologic screening approaches need to be renewed to cover nucleic acid testing in the setting of hemodialysis and all the other high-risk groups associated with it (i.e., blood and organ donors).

30 October 2024 in Health Science Reports
Verified
Journal Article
Open access
MMMohammad Yousef Memar
Mohammad Yousef Memar
MVMasoud Vosughi
Masoud Vosughi
YSYalda Rahbar Saadat
Yalda Rahbar Saadat
MAMohammadreza Ardalan
Mohammadreza Ardalan
MYMina Yekani
Mina Yekani
SVSepideh Zununi Vahed
Sepideh Zununi Vahed
Background and Aims: Urinary tract infections (UTIs) are prevalent among hospitalized patients, constituting the most frequent health‐care infections. Uropathogenic Escherichia coli (UPEC) is leading causative agent of UTIs. The present study was aimed to examine the susceptibility of UPEC isolates obtained from nosocomial cases to antibiotics, as well as their biofilm formation capability and frequency of virulence genes.Methods: A total of 100 UPEC isolates were collected from nosocomial UTIs at Imam Reza Hospitals in Tabriz, Iran, spanning from April 2022 to January 2023. The antimicrobial susceptibility patterns were evaluated using the disk diffusion method, along with the detection of broad‐spectrum β‐lactam enzymes (ESBLs) and carbapenemases. The ability of isolates to form biofilms was assessed using the microtiter‐plate method, while the PCR method was employed to identify the presence of virulence genes.Results: The highest resistance was observed toward piperacillin (82%), followed by aztreonam and ciprofloxacin (81%), while the lowest resistance was found against piperacillin/tazobactam (12%) and meropenem (9%). ESBLs were detected in 62% of the isolates. The microtiter‐plate results revealed strong, moderate, and weak biofilm formation abilities in 32%, 33%, and 24% of the isolates, respectively. The most prevalent virulence gene was fimA (74%) followed by hlyF (68%), papA (44%), papC (32%), iroN (26%), and cnf (20%).Conclusion: The elevated levels of resistance to multiple antimicrobial agents, coupled with the co‐presence of virulence genes and biofilm formation abilities, contribute to the persistence of UPEC‐related infections, particularly in hospitalized patients. These findings underscore the necessity of implementing an effective program to control nosocomial UTIs caused by UPEC in the healthcare centers.

20 June 2023 in Transplant Immunology
Verified
Journal Article
Closed access
ASAnis Sani
Anis Sani
KMKobra Movalled
Kobra Movalled
AKArash Kamanaj
Arash Kamanaj
SHSina Hassannezhad
Sina Hassannezhad
HHHossein Hosseinifard
Hossein Hosseinifard
MAmohammadreza ardalan
mohammadreza ardalan

5 December 2019 in Journal of Nephropathology
Verified
Journal Article
Open access
MSMohsen Akhavan Sepahi
Mohsen Akhavan Sepahi
BNBahram Niknafs
Bahram Niknafs